UNRESECTABLE BREAST CANCER
Clinical trials for UNRESECTABLE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE BREAST CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood test could help doctors switch breast cancer therapy sooner
Disease control Recruiting nowThis study looks at whether a simple blood test can help doctors decide early on if a treatment is working for people with a certain type of advanced breast cancer (HR+ HER2-). About 65 participants will start standard therapy, and those whose blood test shows a poor response wil…
Matched conditions: UNRESECTABLE BREAST CANCER
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for Hard-to-Treat breast cancer: targeted drug duo shows promise
Disease control Recruiting nowThis study tests a combination of two targeted drugs, tucatinib and trastuzumab, in people with advanced breast cancer that has a specific genetic change (HER3 mutation) but does not have high levels of the HER2 protein. Participants have already tried at least two other chemothe…
Matched conditions: UNRESECTABLE BREAST CANCER
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Real-world study eyes new drug for hard-to-treat breast cancer
Disease control Recruiting nowThis study follows about 1,155 adults with HER2-low breast cancer that has spread or cannot be removed by surgery. It compares how long patients stay on a new targeted drug (trastuzumab deruxtecan) versus standard chemotherapy before needing a different treatment. The goal is to …
Matched conditions: UNRESECTABLE BREAST CANCER
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Disease control
Last updated May 22, 2026 14:02 UTC